ニュース

FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
FDA plans to limit COVID vaccine to only high-risk people: What Oklahomans should know
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
米FDA、新型コロナワクチン接種を65歳以上・高リスク者に限定へ
【ワシントンＡＦＰ＝時事】米食品医薬品局（ＦＤＡ）は２０日、新型コロナウイルスワクチンの追加接種を６５歳以上、または深刻な基礎疾患がある人に制限する方針を示した。６５歳未満で基礎疾患のない個人に関しては、ワクチンを製造する製薬会社に新たな臨床試験の実 ...
ブルームバーグ on MSN1 日
新型コロナ、追加接種ワクチン申請にFDAが新たな臨床試験義務付け
健康な成人と子どもを対象とした新型コロナウイルス感染症のブースター接種について、米規制当局は今後、新たな臨床試験で安全性と有効性が確認されることを承認の条件とする。コストのかかる新要件が追加され、将来的にはワクチン接種対象者が絞られる可能性もある。
FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
pharmaphorum1 時間
FDA tightens heart tox warnings on mRNA COVID vaccines
According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and in most cases resolve within a few ...
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Wellbeing Whisper on MSN6 時間
FDA's New Covid-19 Vaccine Strategy Could Leave Millions of Healthy Adults Without Access ...
We have to admit to ourselves that America is deeply divided on the policy issue of repeat COVID-19 vaccine doses or boosters ...
FDA to limit covid shot approval to 65+, those with medical conditions
The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...